Inventor · disambiguated record
Claus Kristensen
Also filed as: KRISTENSEN CLAUS · KRISTENSEN CLAUS STERNBERG
5 granted patents·3 pending applications·24 citations·filing 1995–2023
75Inventor score
Top patents by PatentIndex Score
8 records- 0184US11708569B2Modified recombinant lysosomal alpha-galactosidase A and aspartylglucoaminidase having low mannose-6-phosphate and high sialic acidUNIV COPENHAGEN·Filed 2019·Granted Jul 25, 2023·4 cites·6 claims
- 0275US12325871B2Lysosomal enzymes modified by cell based glycoengineeringUNIV COPENHAGEN·Filed 2023·Granted Jun 10, 2025·0 cites·13 claims
- 0360US5834233AMethod of limiting the survival of genetically engineered microorganisms in their enivronmentGX BIOSYSTEMS AS·Filed 1995·Granted Nov 10, 1998·16 cites·125 claims
- 0460US2011118183A1N-glycosylated human growth hormone with prolonged circulatory half-lifeNOVO NORDISK HEALTHCARE AG·Filed 2009·Application pending·0 cites
- 0555US2011137011A1Hyperglycosylated human coagulation factor ixNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 0651US8871714B2Hyperglycosylated human coagulation factor IXNOVO NORDISK AS·Filed 2012·Granted Oct 28, 2014·0 cites·4 claims
- 0739US6017730AMethod of limiting the survival of genetically engineered microorganisms in their environmentGX BIOSYSTEMS AS·Filed 1998·Granted Jan 25, 2000·4 cites·29 claims
- 0837US2008058255A1Glycosylation-Disrupted Factor VII VariantsNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →